Emcure Pharmaceuticals IPO Overview

  • IPO Dates: Opens on July 3, 2024, and closes on July 5, 2024.
  • Price Band: The shares are priced between ₹960 and ₹1008 per share.
  • Total Issue Size: ₹1,952.03 crores, with a combination of fresh issues and offers for sale.
  • Listing Date: Expected to be listed on July 10, 2024, on BSE and NSE.

Investment and Allotment Process

  • Investor Categories: Allocations are 50% for QIB, 15% for NII, and 35% for RII.
  • Application Process: Can be applied through ASBA via bank accounts or UPI through stock brokers.
  • Lot Size: Minimum of 14 shares, with applications possible for up to 196 shares in 14 lots.

Company and Financial Overview

Emcure Pharmaceuticals, known for its extensive range of pharmaceutical products, operates from 13 manufacturing facilities across India. The company has shown robust financial growth with significant revenues and profitability in the fiscal year 2023-24.

Use of IPO Proceeds

  • Debt Repayment: A part of the proceeds will be utilized to repay or prepay certain outstanding borrowings.
  • General Corporate Purposes: Funds will also be directed towards general corporate purposes to fuel further growth.